Central Texas Angel Network — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Altis Biosystems builds RepliGut®, human intestinal tissue models grown from human intestinal stem cells that provide human-relevant preclinical data for drug absorption, metabolism, toxicity, and disease modeling.
BiotechDeep TechHealthtechMedical DevicesDurham, US
Christopher Sims(Executive Officer)inJimmy Smedley(Executive Officer)inSamuel Franklin(Director)Joseph McMahon(Director)Michael Biron(Executive Officer, Director)
BoardChristopher Perkins(Director)
Co-investorsAtlanta Technology AngelsCheckmate Capital Group LLCHatteras Venture PartnersIDEA NCJohnson Venture PartnersVentureSouth
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.